Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Proposed Acquisition of European Medical Testing Subsidiary (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sernova Corp SEOVF


Primary Symbol: T.SVA

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

Recent & Breaking News (TSX:SVA)

Concerned Shareholders of Sernova Corp. Stand by their Statements

Canada NewsWire April 17, 2023

UPDATE -- Institutional Shareholder Services Inc. Recommends Sernova's Shareholders Vote FOR all Management Nominees on Management's White Proxy

GlobeNewswire April 14, 2023

Institutional Shareholder Services Inc. Recommends Senova's Shareholders Vote FOR all Management Nominees on Management's White Proxy

GlobeNewswire April 14, 2023

Sernova to Present at 2023 Alliance for Regenerative Medicine Cell & Gene Meeting on the Med

GlobeNewswire April 10, 2023

Sernova Responds to Dissident Shareholders' Misleading Statements and Provides Corporate Updates

GlobeNewswire April 6, 2023

Concerned Shareholders of Sernova Corp. Nominate Two Highly Qualified Directors to the Board

Canada NewsWire April 3, 2023

Advance Notice Filed with Sernova Corp. for the Nomination of Two Director Nominees

Canada NewsWire March 22, 2023

Sernova Announces Abstract on First Cohort of its Phase 1/2 Study Involving Islet Allotransplantation into Pre-vascularized Cell Pouch(TM) Selected for Oral Podium Presentation at American Diabetes Association 83rd Scientific Sessions 2023

GlobeNewswire March 22, 2023

Sernova Announces Upcoming Podium Presentation of iPSC and Cell Pouch(TM) Combination Treatment for Type One Diabetes at the 4th IPITA / HSCI / JDRF Summit

GlobeNewswire March 14, 2023

Sernova Announces Initial Islet Transplantation in First Two Patients Enrolled in Second Cohort of its U.S. Phase 1/2 Clinical Trial for Treatment of Type 1 Diabetes

GlobeNewswire March 8, 2023

Sernova to Participate in Upcoming Roth and Oppenheimer Investor Conferences

GlobeNewswire March 2, 2023

Sernova Announces Advancements with its Novel Cell Pouch System(TM) to Preserve Thyroid Function Following Total Thyroidectomy

GlobeNewswire January 30, 2023

Sernova (TSX:SVA) progresses on Cell Pouch device project

Caroline Egan  January 10, 2023

Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes

GlobeNewswire January 10, 2023

Sernova Corp. Announces CEO Succession Plan and Expanded Management Team

GlobeNewswire December 6, 2022

Sernova's (TSX:SVA) implants the first two patients with Cell Pouch in its clinical trial

Brieanna McCutcheon  November 17, 2022

Sernova Announces First Two Patients Implanted with Cell Pouch(TM) in the Second Cohort of its US Phase 1/2 Clinical Trial for Type 1 Diabetes

GlobeNewswire November 17, 2022

Sernova to Participate in the Stifel Healthcare Conference

GlobeNewswire November 4, 2022

Sernova Receives Authorization to Enroll Second Patient Cohort of Phase 1/2 Trial with Cell Pouch System(TM) for Type 1 Diabetes

GlobeNewswire November 3, 2022

Sernova Corp. Announces Change of Auditor

TheNewsWire October 24, 2022